The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Development And Epilepsy - Strategies For Innovative Research To Improve Diagnosis, Prevention And Treatment In Children With Difficult To Treat Epilepsy
Funder
National Health and Medical Research Council
Funding Amount
$456,083.00
Summary
By deciphering pathophysiological mechanisms in epileptogenic developmental disorders and developing mechanism-related, and advanced therapeutic strategies, we expect to discover novel genes and related molecular pathways that are involved in epilepsy and similar disorders. DESIRE will also help preventing the development of the disease after potentially epileptogenic brain insults.
From Brain Maps To Mechanisms: Modelling The Pathophysiology Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$604,513.00
Summary
As the brain ages, the relationship between its structure and function also changes. In this study, I will use detailed computational modelling and extensive analyses of brain dynamics to improve interventional strategies by: 1. Characterising healthy and unhealthy brain dynamics during ageing; 2. Classifying the various subtypes of pathological dynamics; and 3. Predicting pathological neurodegeneration by identifying the earliest signs of perturbations in healthy ageing.
The Effect Of Chronic Intermittent Alcohol Consumption On The Precipitation Of Dementia.
Funder
National Health and Medical Research Council
Funding Amount
$604,644.00
Summary
This proposal examines the relationship between chronic alcohol intake and alcohol-related dementia, and potential interventions for the treatment of alcohol related dementia.
Vascular Cognitive Risk Score: Quantifying The Vascular Burden In Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$627,180.00
Summary
What causes dementia in a patient presenting to a clinic is often uncertain. While there are exciting potential treatments in the pipeline, we need to understand the cause of the disease in a specific patient to make correct treatment decisions. Stroke and other vascular diseases of the brain cause a significant proportion of dementia in the community. Using MRI scanning technology, this project will quantify this burden in a given patient by developing a ‘vascular cognitive risk' (VCR) score.
Novel Targeted Degradable Multifunctional Poly(vinyl-co-ester) Nanoparticles For Alzheimer’s Disease Applications
Funder
National Health and Medical Research Council
Funding Amount
$601,940.00
Summary
Novel biodegradable polymeric nanoparticles for efficient and targeted delivery of Alzheimer related agents to the brain will be developed. The nanocarriers will be fabricated from biocompatible multifunctional compounds and possess the capability to co-deliver diagnostic and therapeutic agents across the blood-brain barrier. These systems are expected to become a new efficient class of brain delivery systems.
Dementia Associated To Diabetes: Prevention Through The Modulation Of Cerebrovascular Integrity
Funder
National Health and Medical Research Council
Funding Amount
$719,770.00
Summary
Diabetic insulin resistance is reported to induce cognitive decline and dementia. An accumulating body of evidence suggest that compromised integrity of neurovascular unit and following changes in cerebral lipid homeostasis may be centrally involved in the neurodegeneration and cognitive deficits. Therefore, the project aims to prevent the insulin resistance-associated cognitive impairment by modulating the integrity of cerebrovasculature and lipid homeostasis.
Combined TMS-EEG For Early Diagnosis Of Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$603,767.00
Summary
Early diagnosis of Alzheimer's disease is key to more effective early intervention. Current biomarkers are expensive and are not suited for detecting the subtle changes in brain function that occur during the initial stages of the disease. Non-invasive brain stimulation is pain-free and inexpensive, and can directly probe brain function in conscious humans. This project will investigate whether these techniques might be used to identify markers of early brain dysfunction in Alzheimer’s disease.
QUARTZ: Quality Of Life After Radiotherapy And-or Steriods
Funder
National Health and Medical Research Council
Funding Amount
$63,000.00
Summary
Lung cancer is the commonest cause of cancer related death worldwide. In this group, one in four people will be diagnosed with brain metastases during their illness. This makes brain metastases a major health resource issue. For this group, the diagnosis of brain metastases is often associated with survival of less than 3 months. It is therefore important that this short survival period, which is often compromised by the effects of the disease, is not compromised further with the use of potentia ....Lung cancer is the commonest cause of cancer related death worldwide. In this group, one in four people will be diagnosed with brain metastases during their illness. This makes brain metastases a major health resource issue. For this group, the diagnosis of brain metastases is often associated with survival of less than 3 months. It is therefore important that this short survival period, which is often compromised by the effects of the disease, is not compromised further with the use of potentially toxic treatment. Whole Brain Radiotherapy (WBRT) is often used to treat these people. There is no current evidence to confirm that WBRT improves their quality of life. Most people with brain metastases routinely receive steroid medicine either as sole treatment or in addition to WBRT. Despite their potential side effects, steroids can control the symptoms of brain metastases and improve a person's quality of life. It is possible that the addition of WBRT adds nothing to steroids used alone or that only subgroups of these people benefit from WBRT. If these subgroups could be identified, treatment could be better tailored to the individual and minimise unnecessary hospital visits for these terminally ill patients. This could also potentially benefit the oncology community by translating into reduced radiotherapy waiting times. This is a unique, international collaborative study which aims to enroll 1000 people over a 3 year period from the UK, Australia and Canada .The main research question in this study is: Do the overall disadvantages of WBRT for lung cancer sufferers outweigh the advantages? It will be comparing the overall combination of quality and duration of survival in a) people receiving steroids and optimal palliative care alone to b) people receiving steroids, optimal palliative care and WBRT. The secondary research aims are to compare the two treatment groups in terms of symptoms experienced by the person and treatment side effects.Read moreRead less
Long-term Outcome Of Individuals Who Had A First-episode Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$1,344,905.00
Summary
The long-term illness course and outcomes of patients treated for first episode psychosis are poorly understood especially in terms of important domains such as social and vocational functioning, physical health, and quality of life. This treated cohort study of a sample of 786 patients, 15 years after their first episode of psychosis will be one of the longest and largest conducted to date. Results of the study will inform clinical practice and policy development.
The Role Of The Neuronal Epigenome In Natural Brain Ageing And The Progression Of Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$584,644.00
Summary
Most cases of Alzheimer's disease are sporadic or late onset, with only ~5% of cases being familial, suggesting a potential role for epigenetics. This project aims to profile the human brain epigenome throughout normal ageing and in Alzheimer's disease so we can determine how disturbed epigenetic states may affect brain function. This research will provide new insights into the role of the epigenome in Alzheimer's disease, enabling crucial advances in understanding its origins.